Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Rectal Neoplasms 2Carcinoma, Hepatocellular 2Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Sarcoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Nasopharyngeal Carcinoma 1Locally Advanced Low Rectal Adenocarcinoma 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1CRC 1Advanced Digestive System Tumor 1

Interventions

toripalimab 1spartalizumab 1Cisplatin 1Cetuximab 1Carboplatin 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Parkinson Disease 4, Autosomal Dominant Lewy Body × spartalizumab × Clear all
NCT06647563 2024-10-18

Neoadjuvant Toripalimab + Chemotherapy ± Cetuximab in Locally Advanced Head and Neck Squamous Cell Carcinoma (Neo-ICT)

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Phase 3 Not yet recruiting
355 enrolled
Head & Neck

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡